Anguraj SadanandamAcademic
Professor in stratification and precision medicine at the ICR
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“Once bowel cancer spreads to other parts of the body, there are very few treatment options available for patients. It is therefore positive that patients can now access the targeted drug bevacizumab on the NHS. However, we know that the majority of patients won't benefit from the drug, meaning thousands of people in England could be facing unpleasant side effects unnecessarily.”
Professor in stratification and precision medicine at the ICR · Hospital discharge / bed-blocking · 27 Aug 2026 · AI to predict how bowel cancer patients will respond to new NHS drug ↗
Source references
- AI to predict how bowel cancer patients will respond to new NHS drugtheguardian.com · 27 Aug 2026
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.